1. Gonzales R, Steiner JF, Lum A, Barrett PHJr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281: 1512–9. 

1. Gonzales R, Steiner JF, Lum A, Barrett PHJr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281: 1512–9. 
2. Sharp HJ, Denman D, Puumala S, Leopold DA. Treatment of acute and chronic rhinosinusitis in the United States, 1999–2002. Arch Otolaryngol Head Neck Surg 2007; 133: 260–5. 
3. Fairlie T, Shapiro DJ, Hersh AL, Hicks LA. National trends in visit rates and antibiotic prescribing for adults with acute sinusitis. Arch Intern Med 2012; 172: 1513–4. 
4. Smith SS, Kern RC, Chandra RK et al. Variations in antibiotic prescribing of acute rhinosinusitis in United States ambulatory settings. Otolaryngol Head Neck Surg 2013; 148: 852–9. 
5. Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA 2012; 307: 685–92.
6. Ahovuo-Saloranta A, Borisenko OV, Kovanen N et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2008: CD000243. 
7. Fokkens WJ, Lund VJ, Mullol J et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology 2012; 50: 1–307. 
8. Smith SR, Montgomery LG, Williams JWJr. Treatment of mild to moderate sinusitis. Arch Intern Med 2012; 172: 510–3. 
9. Rosenfeld RM, Andes D, Bhattacharyya N et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007; 137: S1–31. 
10. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007; p. 1–136. 
11. Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc 2011; 86: 427–443. 
12. Ostryi sinusit. Klinicheskie rekomendatsii. M., 2016. [in Russian]
13. Young Kyung Yoon, Chan-Soon Park, Jae Wook Kim et al. Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections. Infect Chemother 2017; 49 (4): 326–52.
14. Meltzer EO, Hamilos DL, Hadley JA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114: 155–212.
15. Anon JB, Jacobs MR, Poole MD et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004; 130: 1–45. 
16. Rosenfeld RM. Clinical practice guideline on adult sinusitis. Otolaryngol Head Neck Surg 2007; 137: 365–77. 
17. Anzai Y, Jarvik JG, Sullivan SD, Hollingworth W. The cost-effectiveness of the management of acute sinusitis. Am J Rhinol 2007; 21: 444–51. 
18. Balk EM, Zucker DR, Engels EA et al. Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis. J Gen Intern Med 2001; 16: 701–11. 
19. Amin NM, Breadon G. An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis. Clin Ther 1995; 17: 701–7. 
20. Anon JB, Ferguson B, Twynholm M et al. Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains. Ear Nose Throat J 2006; 85: 500, 502, 504. 
21. Arrieta JR, Galgano AS, Sakano E et al. Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis. Am J Otolaryngol 2007; 28: 78–82. 
22. Benninger MS, Payne SC, Ferguson BJ et al. Endoscopically directed middle meatal cultures versus maxillary sinus taps in acute bacterial maxillary rhinosinusitis: a meta-analysis. Otolaryngol Head Neck Surg 2006; 134: 3–9. 
23. Shintani S Smith, Henderson E Ference et al. The prevalence of bacterial infection in acute rhinosinusitis: A systematic review and meta-analysis. Laryngoscope 2015; 125 (1): 57–69.
24. Slavin RG, Spector SL, Bernstein IL et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005; 116: S13–47. 
25. American Academy of Allergy A & Immunology. Choosing Wisely: Five Things Physicians and Patients Should Question. 2012.
26. Meltzer EO, Hamilos DL, Hadley JA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114: 155–212. 
27. Chow AW, Benninger MS, Brook I et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clin Infect Dis 2012; 54: e72–e112. 
28. Fokkens WJ, Lund VJ, Mullol J et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinol Suppl 2012; 50: 1–12. 
29. Chow AW, Benninger MS, Brook I et al. Infectious Diseases Society of America IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012; 54: e72–e112. 
30. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg 2015; 152 (Suppl.): S1–S39. 
31. Gwaltney JMJr, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol. 1992; 90: 457–61. 
32. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999–2000 respiratory surveillance program. Am J Med 2001; 111 (Suppl. 9A): 19S–24S. 
33. Ahovuo-Saloranta A, Rautakorpi UM, Borisenko OV et al. Antibiotics for acute maxillary sinusitis in adults. Cochrane Database Syst Rev 2014: CD000243.
34. Henry DC, Riffer E, Sokol WN et al. Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. Antimicrob Agents Chemother. 2003; 47: 2770–4. 
35. Luterman M, Tellier G, Lasko B, Leroy B. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis. Ear Nose Throat J 2003; 82: 576–80, 582–4. 
36. Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol 1988; 105: 343–9. 
37. Jenkins SG, Farrell DJ, Patel M, Lavin BS. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000–2003: PROTEKT US years 1–3. J Infect 2005; 51: 355–63. 
38. Falagas ME, Karageorgopoulos DE, Grammatikos AP, Matthaiou DK. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol 2009; 67: 161–71.
39. Lemiengre MB, van Driel ML, Merenstein D et al. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev 2012; 10: CD006089. 
40. Jacobs MR. Antimicrobial-resistant Streptococcus pneumoniae: trends and management. Expert Rev Anti Infect Ther 2008; 6: 619–35. 
41. Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010; 16: 217–25. 
42. Karageorgopoulos DE, Giannopoulou KP, Grammatikos AP et al. Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ 2008; 178: 845–54. 
43. Harrison CJ, Woods C, Stout G et al. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother 2009; 63: 511–9. 
44. Desrosiers M, Evans GA, Keith PK et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. J Otolaryngol Head Neck Surg 2011; 40 (Suppl. 2): S99–S193. 
45. Fenoll A, Giménez MJ, Robledo O et al. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin. J Chemother 2008; 20: 175–9. 
46. Fenoll A, Giménez MJ, Robledo O et al. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2008; 27: 75–80. 
47. Sader HS, Jacobs MR, Fritsche TR. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate. Diagn Microbiol Infect Dis 2007; 57 (Suppl): 5S–12S. 
48. Jansen WT, Verel A, Beitsma M et al. Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada. Curr Med Res Opin 2008; 24: 2853–61. 
49. Fenoll A, Aguilar L, Robledo O et al. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. J Antimicrob Chemother 2007; 60: 323–7. 
50. Poachanukoon O, Kitcharoensakkul M. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial. Clin Ther 2008; 30: 1870–9. 
51. Ebell MH, Smith MA, Barry HC et al. Does this patient have strep throat? JAMA 2000; 284: 2912–8. 
52. Gidengil CA, Kruskal BA, Lee GM. Initial antibiotic choice in the treatment of group A streptococcal pharyngitis and return visit rates. J Pediatric Infect Dis Soc 2013; 2: 361–7.